Enter Your Practice Information

Yes No

Yes No


Welcome to the all-new Vetlearn

  • Vetlearn is getting a new home. Starting this fall,
    Vetlearn becomes part of the NAVC VetFolio family.

    You'll have access to the entire Compendium and
    Veterinary Technician archives and get to explore
    even more ways to learn and earn CE by becoming
    a VetFolio subscriber. Subscriber benefits:
  • Over 500 hours of interactive CE Videos
  • An engaging new Community for tough cases
    and networking
  • Three years of NAVC Conference Proceedings
  • All-new articles (CE and other topics) for the entire
    healthcare team

To access Vetlearn, you must first sign in or register.


  • Registration for new subscribers will open in September 2014!
  • Watch for additional exciting news coming soon!
Become a Member

Journal January 2008 (Vol 30, No 1)

NOTE: You have already passed this course.
NOTE: This course is no longer valid for accreditation purposes.

Canine Pituitary Macrotumors

1.The incidence of PMAs in patients with PDH is
2.Which statement(s) regarding functional pituitary macroadenomas in dogs is/are correct?
3.One of the most common manifestations of a pituitary macrotumor is
4.Which endocrine test can distinguish a PMA from a small pituitary tumor?
5.When MRI is used, the normal canine pituitary
6.Complications after transsphenoidal hypophysectomy include
7.Approximately ____ of large pituitary tumors shrink in response to radiation therapy.
8.The median survival time for dogs in which large pituitary tumors were treated with radiation therapy was ____ days.
9.With no therapy, the median survival time for dogs with neurologic signs due to a large pituitary tumor was _____ days.
10.Which statement regarding the prognosis for dogs with large pituitary tumors treated with radiation therapy is correct?
Stay on top of all our latest content — sign up for the Vetlearn newsletters.
  • More